By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Concert Pharmaceuticals, Inc. 

99 Hayden Avenue
Suite 500
Lexington  Massachusetts  02421  U.S.A.
Phone: 781-860-0045 Fax: n/a


SEARCH JOBS


Industry
Pharmaceutical

Segment
Start Up





Company News
Concert Pharmaceuticals, Inc. (CNCE) Release: Biopharma Receives FDA Orphan Drug Designation For CTP-656 For The Treatment Of Cystic Fibrosis 1/20/2017 7:50:57 AM
Concert Pharmaceuticals, Inc. (CNCE) Release: Company Provides Further Details On CTP-656 Development In U.S. And Europe 1/17/2017 7:57:43 AM
Concert Pharmaceuticals, Inc. (CNCE) Initiates Phase 2 Clinical Trial Evaluating CTP-656 For The Treatment Of Cystic Fibrosis 12/21/2016 12:45:20 PM
Concert Pharmaceuticals, Inc. (CNCE) Announces CTP-543 Positive Top-Line Phase 1 Results 12/14/2016 9:31:07 AM
Concert Pharmaceuticals, Inc. (CNCE) Reports Third Quarter 2016 Financial Results And Provides Company Update 11/8/2016 8:23:05 AM
Concert Pharmaceuticals, Inc. (CNCE) To Report Third Quarter 2016 Financial Results On November 8, 2016, And Present At Upcoming Investor Conferences 11/1/2016 11:43:17 AM
Concert Pharmaceuticals, Inc. (CNCE) Presents Poster At 2016 North American Cystic Fibrosis Conference 10/28/2016 8:42:07 AM
Concert Pharmaceuticals, Inc. (CNCE) Announces Upcoming Poster Presentation At North American Cystic Fibrosis Conference 9/23/2016 11:57:54 AM
Concert Pharmaceuticals, Inc. (CNCE) Announces Upcoming Poster Presentation At North American Cystic Fibrosis Conference 9/22/2016 11:05:32 AM
Concert Pharmaceuticals, Inc. (CNCE) Expands Management Team 9/6/2016 11:32:25 AM
12345678910...
//-->